Purpose: To assess the association and correlation of Diabetic Retinopathy with HbA1clevels. Materials and Methods: 100 patients of type 2 diabetics were examined in the present study. Results: Out of 100 patients in the study, the mean age of Diabetes Mellitus is 15.99 years + 5.68 years. The mean of HbA1c in the study population was 9.25 + 1.59. The range of HbA1c was 8.6% to 10.5%. Conclusion: The severity of Diabetic Retinopathy is increased with age and duration of Diabetes Mellitus. The HbA1c levels showed an increase, with the severity of Diabetic Retinopathy. The high HbA1c levels showed the presence of CSME (Clinically Significant Macular Edema).
Introduction
Diabetes is the group of metabolic diseases characterized by hyperglycemia resulting from a defect in insulin secretion, insulin action, or both. It is the most critical disease which can affect nearly every organ system in the body. 1 Diabetes is the most common metabolic abnormality in humans. 2 Type 2 diabetes is the most prevalent form of diabetes constituting nearly 90% of the diabetic population. 3 India with the most significant number of diabetic subjects earned the title Diabetes capital of the world.The presence of diabetic retinopathy indicates microcirculatory dysfunction in other organ systems. 4 Diabetic retinopathy: It is the chronic progressive sight-threatening disease of retinal microvasculature associated with prolonged hyperglycemia. Diabetic retinopathy is the leading cause of preventable blindness in the United States in people 18 to 65 years of age. 5 It used to be 17th cause of blindness but now ascended to 6 positions with an estimated 5.8 million affected diabetic retinopathy patients. 6 HbA1c:N terminal valine residue of erythrocyte hemoglobin becomes glycosylated irreversibly with proportion to circulating glucose concentrations in the blood, and the resultant product is referred to as HbA1c. 7 As the life span of glycosylated Hemoglobin is 120 days, unlike FBS and PPBS, it gives us a long term glycemic values. 8 Henceforth to diagnose pre-diabetes and diabetes, American Diabetic Association is recommending HbA1c is to be considered. The present clinical study was performed to investigate the relationship between glycosylated hemoglobin (HbA1c) levels and the severity of diabetic retinopathy. http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i12.121
Materials and Method
A cross-sectional study was conducted in 100 patients already diagnosed with type 2 diabetes attending OPD at a tertiary care centre, Tumkur. Patients with Diabetic retinopathy changes were included in the study and their HbA1c levels were documented. Patients with other systemic diseases that could manifest as retinal pathology and with hazy ocular media were excluded. After taking informed consent, all patients were examined according to a predesigned proforma. Relevant history regarding diabetes concerningthe age of onset, duration, nature, and effect of treatment received was taken. A general physical examination was performed, followed by a complete ophthalmic examination. A detailed fundus evaluation was performed using direct ophthalmoscopy, indirect ophthalmoscopy, along with slit-lamp biomicroscopy with a +90D lens. The retinopathies were observed and documented by the modified ETDRS classification as follows:
3. Severe NPDR. 4. Early PDR. 5. High-Risk PDR. All patients were subjected to fundus photography. The data obtained from the patients are presented in tabulated forms. Mean, median, and standard deviation are calculated. Data entry was done using an Excel spreadsheet, and descriptive statistics including frequencies of various functional outcomes,are computed using Epi.info. Table 1 shows the demographic data of 100 patients included in our study. The mean age of participants in this study was 63.79 ± 8.47, and out of the 100 participants, M:F ratio was 1.27:1. The mean ag eof 100 patients at diagnosis was 49 ± 5.95 and mean duration of the diabetes was 15.99 ± 5.68. The mean of Glycosylated hemoglobin (HbA1c) in the study population was 9.25 ± 1.59. Among 100 participants, there were 56 Males and 44 Females in our study group, revealing a male predominance in our recruited studypopulation. The male to female ratio was 1.27: 1, as shown in table 2.
Results

Prevalence of Retinopathy
Our study constituted 17% mild NPDR, 18% moderate NPDR, 48% severe NPDR, 13% PDR and 4% high risk PDR. Out of 100 retinopathy patients studied severe and very severe NPDR accounted fornearly half the patients while the other half consisted of early PDR, mild and moderate NPDR, the latter beinghigher than the former as shown in graph 1. Correlation of HbA1c with the severity of Retinopathy Table 3 reveals that there were 85% of mild NPDR cases, 62% of moderate NPDR cases, and 14% of PDR cases in 6.5% -8.5% range of HbA1c. Whereas in HbA1c range of 8.6 % -10.5%, mild and moderate NPDR cases reduced to 15% and 29% respectively, and severe NPDR cases increased to 53%. Early PDR cases raised from 38% in 6.5% -8.5% range of HbA1c to 46% in 8.6 % -10.5%. And high-risk PDR casesraised from 25% to 50% when HbA1c raises from 6.5% -8.5% to 8.6 %-10.5%. This revealed an increasing trend of the severity of retinopathy with raise in HbA1c levels. Mean and Standard Deviation of HbA1c in retinopathy Table 4 shows the means of HbA1c in each level of severity of diabetic retinopathy. The mean of HbA1c in mild NPDR was 7.62 + 0.49. In moderate NPDR, it was 8.66 + 1.48. In severe NPDR 10.06 + 1.42.In Early PDR 9.0 + 1.32 and in High risk PDR 9.48 + 2.09. Therefore, as the severity of retinopathy increased, the mean HbA1c for that level of severity also increased. The standard deviation (S.D) ineach group is small. 
Graph 1 Prevalence of Retinopathy
Discussion
The present study was conducted as a descriptive observational study to determine the correlation of HbA1c levels with diabetic retinopathy. PDR, and 4% high-risk PDR. Regardless of the severity of retinopathy, 23% of cases had CSME. A south Indian study by Mohan R. reported an overall prevalence of NPDR in 6%, while 4% had macular edema, and 4% had PDR. 9 A Chennai study revealed the prevalence of DR was 34.1%. Theprevalence included 30.8% with NPDR, 3.4% with PDR and 6.4% had DME. 10 The differences in the findings could be attributed to variable population Characteristics as the age ofonset, diabetic duration, treatment and adherence.
HbA1c and severity of retinopathy:
Our study revealed that mean values of HbA1c in non-proliferative types of diabetic retinopathy havean indisputable difference. The standard deviation of each level being considerably small, made the differencemore relevant.When the HbA1C values were compared in the groups with increasing severity of retinopathy, risinglevels of HbA1C were noted showing a significant correlation. Therefore, it was pointed out that poor glycemiccontrol led to the worsening of the retinopathy. The Diabetes Control and Complications Trial (DCCT) and the U.K. Prospective Diabetes study (UKPDS) were the two randomized clinical trials that conclusively showed the efficacy of glycemic control inpreventingthe severity of diabetic retinopathy. These studies mentioned that glycemic control was protective for all levels ofretinopathy. 11 HbAlc with CSME: Comparison of the mean of HbA1c in patients with and without CSME revealed a statistically significant association of CSME with HbA1c levels. High glycosylated hemoglobin (HbA1c) level is a well-knownrisk factor for diabetic macular edema. Also, the DCCT had demonstrated that intensive treatment tomaintain blood glucose levels at a normal range reduced the risk of clinically significant macular edema at therate of 23%. 12, 13 A recent study in this regard has shown that mean HbA1c in patients with persistent unilateral CSME was 8.6% and that in bilateral CSME was 9.1%. The same study also revealed that people with type 2 diabetes with persistent CSME havehigher HbA1c values at the time of their disease than patients with resolved CSME.
Conclusion
The value of glycosylated hemoglobin (HbA1c) showed an increasing trend as the severity of diabeticretinopathy increases. The poor metabolic control, as demonstrated by high HbA1c, is significantly associated with the severity of retinopathy and the presence of CSME. From the analysis of our study, we recommend maintaining HbA1c levels below 7.5%, which reduces the risk of progression of diabetic retinopathy. Duration of diabetes and high HbA1c levels are found to be the significant predictors of diabetic retinopathy in typeII diabetes mellitus.
